SKINDERMA Lipolytic Combo Solution | 5 Bottles of 10 ml

Skinderma Lipolytic Combo Solution is a professional-grade solution designed for aesthetic treatments targeting localized fat deposits and body contouring. Its formula combines lecithin with sodium deoxycholate. The box contains five 10-ml vials.

Product description

Lipolytic Combo Solution is used in conjunction with professional lipolysis and body contouring treatments. It is recommended by Skinderma for the management of localized fat and the visual improvement of facial and body contours.

Its formulation is based on two complementary active ingredients: lecithin, used in certain aesthetic treatments targeting adipose tissue, and sodium deoxycholate, known for its effect on fat cells.

This product is not intended as a general weight-loss solution and is not a substitute for a balanced diet or regular physical activity.

Benefits

• Supports programs designed to target localized fat
• Helps reshape the contours
• Suitable for professional facial and body treatments
• A formula enriched with two active ingredients
• Convenient package containing five individual bottles

Indications

Lipolytic Combo Solution is intended for professional treatment protocols involving:

• Localized fat deposits
• Body Contouring
• Defining the Outlines
• Certain areas of the face and body with localized excess fat

Active ingredients

Lecithin

Lecithin is a phospholipid used in certain cosmetic products and aesthetic treatments designed to address the appearance of fat deposits.

Sodium deoxycholate

Sodium deoxycholate is a substance that has a cytolytic effect on fat cells. Its use requires careful selection of treatment areas, appropriate dosing, and strict adherence to the protocol.

Treatment areas

• Face
• Body

The specific areas that can be treated depend on local regulations, the practitioner’s assessment, and the authorized method of application.

Features

• Brand: Skinderma
• Name: Lipolytic Combo Solution
• Category: Professional Lipolytic Solution
• Main active ingredients: lecithin and sodium deoxycholate
• Package Contents: 5 bottles, 10 ml each
• Total capacity: 50 ml
• Recommended areas: face and body

Precautions for use

This product is strictly for use by qualified professionals only. Sodium deoxycholate may cause serious reactions, including pain, swelling, inflammation, tissue damage, or nerve damage, if used improperly.

The route of administration, dosage, approved areas of use, and contraindications must be determined in accordance with the manufacturer’s instructions and applicable regulations. Do not use at home.

Since the manufacturer does not provide a detailed protocol in the product information sheet, no dosage or application method can be specified.

FAQ

What is Skinderma Lipolytic Combo Solution used for?

This solution is designed to complement professional protocols aimed at targeting localized fat and reshaping the contours of the face or body.

What are the active ingredients in Lipolytic Skinderma?

Its formula combines lecithin and sodium deoxycholate.

Does Lipolytic Skinderma help you lose weight?

No. A treatment that targets localized fat deposits is not a general weight-loss treatment. It is not a substitute for a balanced diet or physical activity.

Can this solution be used on the face?

Skinderma lists the face as one of the treatment areas. Eligibility and the exact treatment area must be determined by a qualified professional.

Can Lipolytic Combo Solution be applied to the body?

Yes, the body is one of the areas recommended by the manufacturer, as part of an appropriate professional protocol.

What is the capacity of the product?

The box contains five 10-ml bottles, for a total volume of 50 ml.

Can this product be used at home?

No. The presence of sodium deoxycholate requires that this product be used strictly by professionals due to the risks associated with improper use.

How many sessions are required?

The manufacturer does not specify a standard number of sessions. This depends on the treatment area, the desired outcome, the approved protocol, and the practitioner’s individual assessment.